

English
-
-
Dengue disease awareness
ISID39 minutes -
Dengue Infections in Travelers
Takeda -
Public Health Considerations for Dengue
Takeda -
Adverse Event Management after Dengue Vaccination
Takeda7 minutes -
Case presentations in severe dengue: contemporary approaches to clinical management
Medscape45 minutes -
Management of cases
Takeda1 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Clinical diagnosis and management of dengue
PAHO -
Dengue Clinical Case Management
CDC -
Emerging Issues in Pediatric Dengue
WSPID50 minutes -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Resources for patient support
Takeda3 minutes -
Dengue virus infections among European travellers, 2015 to 2019
Takeda2 minutes -
Dengue: a global threat
WSPID38 minutes -
Latest Research on Dengue Science
Takeda -
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19
Takeda2 minutes -
NS1 and its potential association with severe dengue
Takeda3 minutes -
Effects of dengue
Takeda7 minutes -
Dengue serotypes
Takeda4 minutes -
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
Takeda2 minutes -
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis
Takeda2 minutes -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023